難治性T細胞性腫瘍に対するOff-the-shelf CAR-NK細胞を用いた複合免疫療法の開発

• Project/Area Number: 25K22606
• Research Category: Grant-in-Aid for Challenging Research (Exploratory)
• Allocation Type: Multi-year Fund
• Review Section: Medium-sized Section 52:General internal medicine and related fields
• Research Institution: University of Toyama
• Principal Investigator: 今井 千速 富山大学, 学術研究部医学系, 教授 (90419284)
• Project Period (FY): 2025-06-27 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000); Fiscal Year 2027: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000); Fiscal Year 2026: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000); Fiscal Year 2025: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)